• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道中的顶复门原虫感染

Apicomplexan infections in the gut.

作者信息

Wilhelm C L, Yarovinsky F

机构信息

Departments of Immunology, University of Texas Southwestern Medical School, Dallas, TX, USA.

出版信息

Parasite Immunol. 2014 Sep;36(9):409-20. doi: 10.1111/pim.12115.

DOI:10.1111/pim.12115
PMID:25201405
Abstract

Toxoplasma gondii and Cryptosporidium parvum are intracellular protozoan parasites that establish infection through the small intestinal bowel after the ingestion of contaminated food products. These Apicomplexan parasites have emerged as an important cause of chronic and fatal disease in immunodeficient individuals, in addition to being investigated as possible triggers of inflammatory bowel disease. T. gondii disseminates to the brain and other tissues after infection, whereas C. parvum remains localized to the intestine. In the following review, we will discuss the pathogenesis of these parasitic diseases in the small intestine, the site of initial invasion. Themes include the sequence of invasion, the structure of Th1 immunity provoked by these parasites and the contribution of intestinal microbiota to the development of the mucosal immune response.

摘要

刚地弓形虫和微小隐孢子虫是细胞内原生动物寄生虫,摄入受污染的食品后会通过小肠引发感染。除了被研究作为炎症性肠病的可能触发因素外,这些顶复门寄生虫已成为免疫缺陷个体慢性和致命疾病的重要病因。刚地弓形虫感染后会扩散至大脑和其他组织,而微小隐孢子虫则局限于肠道。在以下综述中,我们将讨论这些寄生虫病在小肠(初始入侵部位)的发病机制。主题包括入侵顺序、这些寄生虫引发的Th1免疫结构以及肠道微生物群对黏膜免疫反应发展的作用。

相似文献

1
Apicomplexan infections in the gut.肠道中的顶复门原虫感染
Parasite Immunol. 2014 Sep;36(9):409-20. doi: 10.1111/pim.12115.
2
Cryptosporidium and host resistance: historical perspective and some novel approaches.隐孢子虫与宿主抗性:历史视角及一些新方法
Anim Health Res Rev. 2003 Jun;4(1):53-62. doi: 10.1079/ahrr200352.
3
Mucosal immunity in Toxoplasma gondii infection.弓形虫感染中的黏膜免疫
Parasite. 2008 Sep;15(3):389-95. doi: 10.1051/parasite/2008153389.
4
Activity of (1-benzyl-4-triazolyl)-indole-2-carboxamides against Toxoplasma gondii and Cryptosporidium parvum.(1-苄基-4-三唑基)-吲哚-2-甲酰胺类化合物抗弓形虫和微小隐孢子虫的活性。
Int J Parasitol Drugs Drug Resist. 2022 Aug;19:6-20. doi: 10.1016/j.ijpddr.2022.04.001. Epub 2022 Apr 16.
5
Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.在原发性和激发性微小隐孢子虫感染期间,干扰素-γ和白细胞介素-12p40基因敲除小鼠肠道黏膜及全身Th1/Th2细胞因子反应的动态变化
Immunobiology. 2009;214(6):454-66. doi: 10.1016/j.imbio.2008.11.015. Epub 2009 Jan 19.
6
Border maneuvers: deployment of mucosal immune defenses against Toxoplasma gondii.边界操作:黏膜免疫防御对刚地弓形虫的部署。
Mucosal Immunol. 2014 Jul;7(4):744-52. doi: 10.1038/mi.2014.25. Epub 2014 Apr 9.
7
Opportunism and AIDS: walking the tightrope.机会主义与艾滋病:走在钢丝上。
Parasitol Today. 1999 Feb;15(2):45-6. doi: 10.1016/s0169-4758(98)01372-6.
8
Cryptosporidiosis: host immune responses and the prospects for effective immunotherapies.隐孢子虫病:宿主免疫反应和有效的免疫治疗前景。
Expert Rev Anti Infect Ther. 2011 Nov;9(11):1077-86. doi: 10.1586/eri.11.123.
9
Boromycin Has Potent Anti- and Anti- Activity.硼替佐米具有强大的抗肿瘤和抗血管生成活性。
Antimicrob Agents Chemother. 2021 Mar 18;65(4). doi: 10.1128/AAC.01278-20.
10
Innate immune responses against Cryptosporidium parvum infection.先天性免疫应答对抗微小隐孢子虫感染。
Parasite Immunol. 2013 Feb;35(2):55-64. doi: 10.1111/pim.12020.

引用本文的文献

1
Parasites and Microbiota: Dual Interactions and Therapeutic Perspectives.寄生虫与微生物群:双重相互作用及治疗前景
Microorganisms. 2024 Oct 16;12(10):2076. doi: 10.3390/microorganisms12102076.
2
Intranasal immunisation with recombinant Toxoplasma gondii uridine phosphorylase confers resistance against acute toxoplasmosis in mice.鼻腔内接种重组弓形虫尿嘧啶磷酸核糖基转移酶可使小鼠抵抗急性弓形虫病。
Parasite. 2023;30:46. doi: 10.1051/parasite/2023047. Epub 2023 Nov 2.
3
Interferon-Inducible E3 Ligase RNF213 Facilitates Host-Protective Linear and K63-Linked Ubiquitylation of Toxoplasma gondii Parasitophorous Vacuoles.
干扰素诱导 E3 连接酶 RNF213 促进弓形虫滋养体空泡中宿主保护性的线性和 K63 连接泛素化。
mBio. 2022 Oct 26;13(5):e0188822. doi: 10.1128/mbio.01888-22. Epub 2022 Sep 26.
4
Induction of IL-12p40 and type 1 immunity by Toxoplasma gondii in the absence of the TLR-MyD88 signaling cascade.弓形虫诱导 IL-12p40 和 1 型免疫而不依赖 TLR-MyD88 信号级联。
PLoS Pathog. 2021 Oct 1;17(10):e1009970. doi: 10.1371/journal.ppat.1009970. eCollection 2021 Oct.
5
C5aR1 Activation Drives Early IFN-γ Production to Control Experimental Infection.C5aR1 激活驱动早期 IFN-γ 产生以控制实验性感染。
Front Immunol. 2020 Jul 8;11:1397. doi: 10.3389/fimmu.2020.01397. eCollection 2020.
6
Micromanaging Immunity in the Murine Host vs. the Mosquito Vector: Microbiota-Dependent Immune Responses to Intestinal Parasites.在小鼠宿主与蚊子媒介中对免疫的微观管理:肠道寄生虫的依赖于微生物组的免疫反应。
Front Cell Infect Microbiol. 2018 Sep 3;8:308. doi: 10.3389/fcimb.2018.00308. eCollection 2018.
7
Parasite-Microbiota Interactions With the Vertebrate Gut: Synthesis Through an Ecological Lens.寄生虫-微生物群与脊椎动物肠道的相互作用:基于生态学视角的综合研究
Front Microbiol. 2018 May 14;9:843. doi: 10.3389/fmicb.2018.00843. eCollection 2018.
8
Evaluation of a coccidia vaccine using spray and gel applications.喷雾和凝胶应用评估球虫疫苗。
Poult Sci. 2018 May 1;97(5):1544-1553. doi: 10.3382/ps/pey011.
9
Under control: how a dietary additive can restore the gut microbiome and proteomic profile, and improve disease resilience in a marine teleostean fish fed vegetable diets.受控制状态:一种饮食添加剂如何恢复肠道微生物组和蛋白质组谱,并提高以植物性饮食喂养的海洋硬骨鱼类的疾病抵抗力。
Microbiome. 2017 Dec 28;5(1):164. doi: 10.1186/s40168-017-0390-3.
10
Prevalence of Cryptosporidium Infection among Inhabitants of 2 Rural Areas in White Nile State, Sudan.苏丹白尼罗州两个农村地区居民隐孢子虫感染率
Korean J Parasitol. 2015 Dec;53(6):745-7. doi: 10.3347/kjp.2015.53.6.745. Epub 2015 Dec 31.